Skip to main content
. 2022 Jan 5;11:780655. doi: 10.3389/fonc.2021.780655

Figure 4.

Figure 4

Current approaches of KRAS-mutant NSCLC. NSCLC, non-small cell lung cancer; KRAS, kirsten rat sarcoma viral oncogene homolog; PD-1, programmed cell death protein 1; PD-L1, programmed cell death-ligand 1; CTLA4, cytotoxic T-lymphocyte-associated protein 4; Raf, rat fibrosarcoma; MEK, mitogen-activated protein kinase kinase; PI3K, phosphoinositide 3-kinase; Akt/PKB, protein kinase B.